Shane Storey

Shane Storey

analyst Unknown

Shane Storey is an analyst at Wilsons Advisory, known for providing insights into the financial performance of major companies. Recently, he commented on CSL's restructuring plans and the potential impact of Trump’s pharmaceutical tariffs on the company's stock valuation, suggesting that a lower earnings multiple might be appropriate for CSL given its wavering earnings growth despite prior successes.

Global Media Ratings
Dominance
0.00%
Persistence
0 wks
Reach
0
Power
0$
Sentiment
0.00
Countries Mentioned

No country-level mention data available.

Interactive World Map

Each country's color is based on "Mentions" from the table above.

Recent Mentions

Australia Australia: Shane Storey is an analyst from Wilsons Advisory who commented on CSL's earnings and restructuring plans. 5

The Sydney Morning Herald: How Trump tariffs and RFK loom large for Australian health and biopharmaceutical giant